Latest Leadership Change News

DMC Mining Limited progresses its strategic acquisition of the Firawa and Labé uranium projects in Guinea, while navigating key board appointments and capital raising efforts ahead of ASX re-admission.

Indiana Resources Limited reports significant high-grade gold intersections at its Minos deposit in South Australia, alongside a robust cash position and strategic leadership appointment.

Investor Centre Limited’s December quarter report reveals a strategic pivot with the withdrawal of its capital raising prospectus, the appointment of a new director, and ongoing talks to expand its wholesale financial services.

Environmental Clean Technologies Limited has formed a joint venture and launched field trials for its innovative COLDry lignite-nitrogen fertiliser, marking a pivotal step toward commercialisation and revenue generation.

Breakthrough Mineral Limited reports a mixed quarterly cash flow with significant exploration expenditure offset by strong financing inflows and plans for reduced corporate costs.

Genmin Limited has appointed a new CEO and Chair, improved its ESG rating to BBB, and made significant progress towards developing its Baniaka iron ore project in Gabon, targeting production in 2026.

Ten Sixty Four Limited’s latest quarterly report reveals a notable decline in gold output and cash reserves, alongside steady progress on key projects and a pivotal restructuring agreement.

Pacific Nickel Mines Limited has paused its Kolosori Nickel Project due to operational setbacks and a challenging nickel price environment, entering voluntary suspension while negotiating critical financing with Glencore.

Culpeo Minerals reports promising copper mineralisation results at its Fortuna Project and announces key leadership changes, positioning the company for an active 2025 exploration season.

Western Gold Resources Limited has secured expanded mining approvals, confirmed strong metallurgical recoveries, and updated its mineral resource estimate at the Gold Duke Project, positioning the company for a transition to production.

Great Northern Minerals Limited reports significant progress in the sale of its Golden Ant Mining project, with a $1.3 million Earn-In Stage payment expected soon, alongside notable board changes and strategic project reviews.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.